The Merck subsidiary has yeast that can copy human cell chemistry.
|
A lot of venture capitalists—maybe too many—have been snapping up opportunities in spinal devices.
|
Drug developer Merrimack grabs $65M; Lung device maker Spiration gets $13.4M; Treating colon cancer with Celebrex.
|
Influential medical journal says drug giant submitted false data about heart problems linked to its pain drug Vioxx.
|
Remicade takes on Enbrel; legislation for child drug research; Pfizer’s Celebrex gets pickings from Bextra; new South African AIDS figures.
|
Vertex shares jump 20 percent; $15 million goes to BioniCare; Wilex raises $39-million Series C; NeoRx cuts its work force.
|
A study finds 15 medical treatments linked to serious reactions, including 170 deaths.
|
Wharton Biotechnology Partners and others pony up $37.3 million for Merrimack to advance in FDA arthritis trials.
|